Established in 1996, the European Institute of Women’s Health,clg, (EIWH) is a non-governmental organisation, promoting gender equity in public health, research and social policies across Europe. The EIWH promotes gender -specific bio-medical and socioeconomic research that addresses sex (biological) and gender (social) based differences to ensure access to quality treatment and care for women across the lifespan. Using an evidence based approach, the EIWH aims to reduce inequalities in health, in particular due to gender, age and socioeconomic status, ethnicity etc by highlighting that gender/sex is an important determinant of health. EIWH ongoing policy briefings: accessible documents on health issues and policy including sections and briefings on maternal care, diabetes CVD, cancer among others. Reports, position papers and consultations: on women’s health topics, such as the Revision of the Clinical Trials Regulation, Impact of Covid-19 on Women, Sex and Gender in Medical Education. EIWH has worked closely with the European Commission, Member States and the World Health Organisation to place gender and women’s health on the health and research agenda. EIWH is a member of the committee that represents patients and consumer with the European Medicines Agency (EMA), as well as the patient representative ,European Centre for Disease Control and Prevention (ECDC) Advisory Forum. The EIWH has been a member of the EU Commission EU Horizon2020 advisory Group for the Societal Challenge 1 ‘Health, Demographic Change and Well-being (H2020 AG SC1) and the Gender Advisory Group. The EIWH has worked with the WHO over the years as expert advisor and has contributed to the WHO Women’s Health Strategy, which includes the health of women across the lifecourse.